Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011788
Filing Date
2024-08-12
Accepted
2024-08-12 06:30:34
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20240630x10q.htm   iXBRL 10-Q 2238873
2 EX-10.1 mgtx-20240630xex10d1.htm EX-10.1 18902
3 EX-31.1 mgtx-20240630xex31d1.htm EX-31.1 11372
4 EX-31.2 mgtx-20240630xex31d2.htm EX-31.2 11322
5 EX-32.1 mgtx-20240630xex32d1.htm EX-32.1 6763
6 EX-32.2 mgtx-20240630xex32d2.htm EX-32.2 6771
  Complete submission text file 0001558370-24-011788.txt   8657604

Data Files

Seq Description Document Type Size
7 EX-101.SCH mgtx-20240630.xsd EX-101.SCH 58164
8 EX-101.CAL mgtx-20240630_cal.xml EX-101.CAL 52230
9 EX-101.DEF mgtx-20240630_def.xml EX-101.DEF 241866
10 EX-101.LAB mgtx-20240630_lab.xml EX-101.LAB 443506
11 EX-101.PRE mgtx-20240630_pre.xml EX-101.PRE 389486
75 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20240630x10q_htm.xml XML 1451586
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 241194666
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)